Literature DB >> 27606814

Isolation, Culture and Identification of Choriocarcinoma Stem-Like Cells from the Human Choriocarcinoma Cell-Line JEG-3.

Jingting Cai1, Tianfang Peng, Jing Wang, Jingli Zhang, Hui Hu, Dihong Tang, Chaonan Chu, Ting Yang, Huining Liu.   

Abstract

BACKGROUND/AIMS: Cancer stem cells (CSCs) exhibit enhanced proliferative capacity and resistance to chemotherapy; however, choriocarcinoma CSCs have not yet been reported. In this study the human choriocarcinoma cell line JEG-3 was cultured in serum free media, and the characteristics of suspension and parental adherent JEG-3 cells were compared.
METHODS: Cell proliferation, colony-formation, soft agar clonogenicity, and transwell invasion assays were performed in vitro, and tumor xenografts in BALB/c nude mice were used to evaluate stem cell properties.
RESULTS: In serum-supplemented medium (SSM), JEG-3 cells were 4.51 ± 1.71% CD44+, 7.67 ± 2.67% CD133+, and 13.85 ± 2.95% ABCG2+. In serum-free medium (SFM), the expression of these markers increased to 53.08 ± 3.15%, 47.40 ± 2.67%, and 78.70 ± 7.16%, respectively. Moreover, suspension JEG-3 cells exhibited enhanced colony-formation capability as well as invasive and proliferative ability in vitro, alongside enhanced tumorigenic properties in vivo. Suspension JEG-3 cells also exhibited resistance to the chemotherapeutic drugs methotrexate, fluorouracil and etoposide. When seeded in serum supplemented medium, suspension JEG-3 cells readopted an adherent phenotype and continued to differentiate with no significant difference in the morphology between suspension and parent cells.
CONCLUSION: In this study, choriocarcinoma stem-like cells (CSLCs) were isolated from the human choriocarcinoma JEG-3 cell line by SFM culture and characterized.
© 2016 The Author(s) Published by S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27606814     DOI: 10.1159/000447845

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  10 in total

1.  Role of AhR in regulating cancer stem cell-like characteristics in choriocarcinoma.

Authors:  Chenchun Wu; Shuran Yu; Qianxia Tan; Peng Guo; Huining Liu
Journal:  Cell Cycle       Date:  2018-10-18       Impact factor: 4.534

2.  Discovery and characterization of circulating tumor cell clusters in neuroendocrine tumor patients using nanosubstrate-embedded microchips.

Authors:  Na Sun; Yingying Yang; Hui Miao; Peter Redublo; Hongtao Liu; Wenfei Liu; Yen-Wen Huang; Pai-Chi Teng; Ceng Zhang; Ryan Y Zhang; Matthew Smalley; Peng Yang; Shih-Jie Chou; Kevin Huai; Zhicheng Zhang; Yi-Te Lee; Jasmine J Wang; Jing Wang; Icy Y Liang; Tiffany X Zhang; Dongyun Zhang; Li Liang; Paul S Weiss; Edwin M Posadas; Timothy Donahue; J Randolph Hecht; Martin S Allen-Auerbach; Emily K Bergsland; Thomas A Hope; Renjun Pei; Yazhen Zhu; Hsian-Rong Tseng; Anthony P Heaney
Journal:  Biosens Bioelectron       Date:  2021-12-03       Impact factor: 12.545

3.  Curcumol Controls Choriocarcinoma Stem-Like Cells Self-Renewal via Repression of DNA Methyltransferase (DNMT)- and Histone Deacetylase (HDAC)-Mediated Epigenetic Regulation.

Authors:  Zheng Peng; Wenjun Zhou; Chun Zhang; Huining Liu; Yi Zhang
Journal:  Med Sci Monit       Date:  2018-01-24

4.  BRCA1 affects the resistance and stemness of SKOV3-derived ovarian cancer stem cells by regulating autophagy.

Authors:  Yue You; Fang-Fang Bi; Ying Jiang; Ye-Tao Xu; Yuan-Yuan An; Da Li; Qing Yang
Journal:  Cancer Med       Date:  2019-01-12       Impact factor: 4.452

5.  SLAMF1 Promotes Methotrexate Resistance via Activating Autophagy in Choriocarcinoma Cells.

Authors:  Dazun Shi; Yu Zhang; Yan Tian
Journal:  Cancer Manag Res       Date:  2020-12-30       Impact factor: 3.989

6.  DPP4 Regulates DHCR24-Mediated Cholesterol Biosynthesis to Promote Methotrexate Resistance in Gestational Trophoblastic Neoplastic Cells.

Authors:  Weijie Yuan; Wenjing Yong; Jing Zhu; Dazun Shi
Journal:  Front Oncol       Date:  2021-12-02       Impact factor: 6.244

7.  miR-497-5p/SALL4 axis promotes stemness phenotype of choriocarcinoma and forms a feedback loop with DNMT-mediated epigenetic regulation.

Authors:  Zheng Peng; Yi Zhang; Dazun Shi; Yanyan Jia; Huirong Shi; Huining Liu
Journal:  Cell Death Dis       Date:  2021-11-03       Impact factor: 8.469

8.  VEGF-B targeting by aryl hydrocarbon receptor mediates the migration and invasion of choriocarcinoma stem-like cells.

Authors:  Qianxia Tan; Jingting Cai; Jingping Peng; Cui Hu; ChenChun Wu; Huining Liu
Journal:  Cancer Cell Int       Date:  2022-06-30       Impact factor: 6.429

9.  Quantitative Proteomic Profiling Identifies SOX8 as Novel Regulator of Drug Resistance in Gestational Trophoblastic Neoplasia.

Authors:  Fu Jun; Zheng Peng; Yi Zhang; Dazun Shi
Journal:  Front Oncol       Date:  2020-04-28       Impact factor: 6.244

10.  Circulating trophoblast cell clusters for early detection of placenta accreta spectrum disorders.

Authors:  Yalda Afshar; Jiantong Dong; Pan Zhao; Lei Li; Shan Wang; Ryan Y Zhang; Ceng Zhang; Ophelia Yin; Christina S Han; Brett D Einerson; Tania L Gonzalez; Huirong Zhang; Anqi Zhou; Zhuo Yang; Shih-Jie Chou; Na Sun; Ju Cheng; Henan Zhu; Jing Wang; Tiffany X Zhang; Yi-Te Lee; Jasmine J Wang; Pai-Chi Teng; Peng Yang; Dongping Qi; Meiping Zhao; Myung-Shin Sim; Ruilian Zhe; Jeffrey D Goldstein; John Williams; Xietong Wang; Qingying Zhang; Lawrence D Platt; Chang Zou; Margareta D Pisarska; Hsian-Rong Tseng; Yazhen Zhu
Journal:  Nat Commun       Date:  2021-08-03       Impact factor: 17.694

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.